CEA和D-二聚体检测对胃癌诊断及手术后患者预后的评估价值
The Value of CEA and D-Dimer Detection in the Diagnosis of Gastric Cancer and the Prognosis of Patients after Surgery
DOI: 10.12677/ACM.2020.107175, PDF,   
作者: 臧龙龙, 刘 睿:青岛大学医学部,山东 青岛;张红军:青岛大学附属医院肿瘤综合治疗科,山东 青岛
关键词: 癌胚抗原D-二聚体胃癌预后Carcinoembryonic Antigen D-Dimer Gastric Cancer Prognosis
摘要: 目的:通过检测胃癌患者手术前癌胚抗原(CEA)及D-二聚体浓度,研究其与胃癌检测阳性率及预后之间的关系。方法:收集胃癌患者手术前血液学指标及基本信息,用Kaplan-Meier法绘制生存曲线,用Cox比例风险模型进行多因素分析。结果:早期组胃癌患者术前CEA及D-二聚体浓度显著低于晚期组,联合检测CEA及D-二聚体较单项检测胃癌阳性率更高。血清D-二聚体浓度与患者术后生存时间相关,肿瘤分期是影响患者生存的独立预后因素。结论:联合检测CEA及D-二聚体在提高胃癌检出率、评估患者预后方面可发挥积极作用。
Abstract: Objective: To study the relationship between the pre-operative carcinoembryonic antigen (CEA) and D-dimer concentration in gastric cancer patients and the positive rate and prognosis of gastric cancer detection. Methods: Collect the hematological indexes and basic information of gastric cancer patients before operation, use Kaplan-Meier method to draw survival curve, and use Cox proportional hazard model for multi-factor analysis. Results: The concentration of CEA and D-dimer in patients with gastric cancer in the early group was significantly lower than that in the late group. The combined detection of CEA and D-dimer was higher than the single detection of gastric cancer. Serum D-dimer concentration is related to the survival time of patients after surgery, and tumor stage is an independent prognostic factor that affects the survival of patients. Conclusion: The combined detection of CEA and D-dimer can play an active role in improving the detection rate of gastric cancer and evaluating the prognosis of patients.
文章引用:臧龙龙, 刘睿, 张红军. CEA和D-二聚体检测对胃癌诊断及手术后患者预后的评估价值[J]. 临床医学进展, 2020, 10(7): 1151-1155. https://doi.org/10.12677/ACM.2020.107175

参考文献

[1] 沙宗美, 鲍扬漪. D-二聚体和肿瘤标记物在胃癌中的诊断价值[J]. 检验医学与临床, 2020, 17(10): 1380-1383.
[2] 王静雷, 杨一兵, 耿云霞, 等. 1990-2017年中国胃癌发病、患病及死亡状况趋势分析[J]. 中国慢性病预防与控制, 2020, 28(5): 321-325.
[3] 任婷, 赵丽娇, 钟儒刚. 重金属污染物诱发胃癌作用的研究进展[J]. 化学试剂, 2020(3): 1-8.
[4] 中国幽门螺杆菌根除与胃癌防控的专家共识意见(2019年, 上海) [J]. 中华健康管理学杂志, 2019(4): 285-291.
[5] 朱思莹, 冀明. 早期胃癌的规范化诊断和治疗[J]. 中华内科杂志, 2020(3): 236-239.
[6] Deng, K., Yang, L., Hu, B., et al. (2015) The Prognostic Significance of Pretreatment Serum CEA Levels in Gastric Cancer: A Meta-Analysis including 14651 Patients. PloS ONE, 10, e0124151. [Google Scholar] [CrossRef] [PubMed]
[7] 张理想, 韩文秀, 韦之见, 等. D-二聚体对胃癌患者的转移诊断价值及评估预后的研究[J]. 国际外科学杂志, 2017, 44(2): 99-103+45.
[8] 何莎, 陈蕾. D-二聚体与结直肠癌、胃癌、胰腺癌的预后关系[J]. 转化医学杂志, 2019, 8(4): 248-251.
[9] 何欢, 刘泽涵, 李其林. 癌栓及D-二聚体水平与胃癌患者的临床病理特征及预后关系[J]. 中国普外基础与临床杂志, 2019, 26(9): 1077-1082.
[10] 彭方兴, 袁三英, 吴宸, 等. 胃癌患者手术前后外周血D-二聚体与CA724水平测定及意义[J]. 海南医学, 2016, 27(22): 3648-3651.